Posted by goreng_kaki > 2020-12-11 09:27 | Report Abuse

Another shameful day for harta, useless management pergi manpus sekeluarga

Posted by Silentreader88 > 2020-12-11 10:16 | Report Abuse

boooo for harta. shameful

Posted by LaoTzeAhSir > 2020-12-11 10:59 | Report Abuse

bullshlt harta. Two days droppind diverge from its peers

Posted by Silentreader88 > 2020-12-11 11:03 | Report Abuse

useless management and rubbish.

Posted by idkdontaskmelol > 2020-12-11 11:07 | Report Abuse

Hooray laotzeahsir tio burn! Heng ah!! Sure tio burn in c52. Donno play don play kekekeke

Posted by goreng_kaki > 2020-12-11 11:16 | Report Abuse

最烂管理层非harta莫属，asp不起赚不到钱，股价跌又不扶盘，下次谁敢说harta是间好公司，稳定的公司我会毫不犹豫一巴盖下去

Posted by Pgraduate123 > 2020-12-11 12:00 | Report Abuse

HURRY LIMIT DOWN...

Posted by Pgraduate123 > 2020-12-11 12:02 | Report Abuse

Rm10. 00 Lai liao

Posted by Pgraduate123 > 2020-12-11 12:03 | Report Abuse

10 mean 5 loh..... Sit side by side kossan 5.48 one for one bonus...

Posted by genghis > 2020-12-11 12:07 | Report Abuse

boss kuan waiting at 12 with his m16 to kill the sellers.

Posted by Pgraduate123 > 2020-12-11 12:13 | Report Abuse

Boss Kuan sitting enjoying Chinese tea now..
No eye see lol..

Posted by WealthSoWonderful > 2020-12-11 12:59 | Report Abuse

TOPGLOVE FOR LONG TERM INVESTMENT: A QUICK PRIMER

TopGlove IPO price RM2.70 March 2001

2,000 units = RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

Today 244,608 units x RM8.70/unit = RM2,128,089

Capital Appreciation = From RM5,400 to RM2,128,089 in just 19 years

This is clear solid undoubtable undeniable evidence of the awesome benefit by way of exponential growth that you get from investing long term in TopGlove

Anyways, this is not a call for buy or sell, but just sharing of some inspirational motivational confidence-building information.

Do your own due diligence

Invest at your own risk

Posted by LaoTzeAhSir > 2020-12-11 13:42 | Report Abuse

Free fall Harta. up the least, drop the most.

Posted by investmalysia > 2020-12-11 13:52 | Report Abuse

IB tp around 22 to 24 wor

Posted by investmalysia > 2020-12-11 13:53 | Report Abuse

RM10 upside wor

Posted by Pgraduate123 > 2020-12-11 14:02 | Report Abuse

Target is just a target.... If they said target 45 then how? Jump in at rm35 is it?
If I said target rm8.45 sen, then how.. Limit Down loh...
Anyhow fair value is rm 8.50, you just wait

Posted by WeLoveSarawak > 2020-12-11 14:32 | Report Abuse

ya remember when things were rosy a few months ago, some bank target topglove RM100 ...what ridiculous targeting LOL

Posted by whenarmada > 2020-12-11 15:03 | Report Abuse

i was so lucky to dispose at RM19. I dont trust this company anymore, It was a nightmare to see it drop to RM12. so many other better counters are available now

Posted by Lewis Lee > 2020-12-11 15:04 | Report Abuse

Yes !!! Please drop some more some more !! All the way to 12.00 !! please !
Those fucking stupid fund managers , newbies, punters , speculators please sell cheap at 12.00 to me !!! thank you !!!

Posted by investmalysia > 2020-12-11 15:08 | Report Abuse

Ya lor. Better buy tenaga. Much more safer than glove counters

Posted by LaoTzeAhSir > 2020-12-11 15:29 | Report Abuse

got EPF got disaster

Posted by goreng_kaki > 2020-12-11 15:34 | Report Abuse

号称最好的公司本身就是个耻辱，ASP起最少，股价跌最多，好笑不?哈哈哈哈哈哈

Posted by KML889 > 2020-12-11 15:37 | Report Abuse

呸呸呸， 烂臭股。

Posted by Lewis Lee > 2020-12-11 15:39 | Report Abuse

Yess, if you have no patient to wait for huge gain by 2021, please dump all your shares until the price drop to 12 and below for me & other value investors to collect at cheap !!
please dump dump dump !! Thank you

Posted by Lewis Lee > 2020-12-11 15:41 | Report Abuse

No need to curse this counter, please just cut loss and dump all your holding together with EPF until it goes down to 12 , please please please !! thank you !

Posted by mindofgain > 2020-12-11 15:55 | Report Abuse

When epf bought the share , you should always alert

Posted by Pgraduate123 > 2020-12-11 15:58 | Report Abuse

Lewis Lee - your lucky day will come reaalll soon. no need 12.....rm 8.60 also waiting for you there

Posted by Snowpiercer > 2020-12-11 16:00 | Report Abuse

All these companies really need to have very generous dividend otherwise it will not be supported as glove beyond 2021 will be tough

Posted by stevenckheng > 2020-12-11 16:08 | Report Abuse

waaa 13.6 fire wall, can buy ?

Posted by NPRA1985 > 2020-12-11 16:30 | Report Abuse

I think institutions have already mostly withdrawn from glove counters and moved on the recovery theme counters leaving mostly retailers in the glove counters. Please correct me if am wrong...

Posted by roshazli > 2020-12-11 16:36 | Report Abuse

Fact box: When and which Covid-19 vaccines are likely to be available in Asia

BEIJING/TOKYO/SEOUL/MANILA/TAIPEI/JAKARTA/DHAKA/HANOI (Dec 11): Trial data from Pfizer Inc with partner BioNTech SE, Moderna Inc and AstraZeneca Plc has shown their experimental vaccines are effective in preventing novel coronavirus infection.
While regulatory processes are underway, few Asian countries expect to receive significant amounts of the vaccines initially. Here are estimated distribution time lines, supply deals announced and clinical trials being held in the region.

Australia
The country has secured around 140 million doses: 53.8 million from AstraZeneca, 51 million from Novavax Inc, 10 million from Pfizer, and 25.5 million from distribution programme COVAX.
It expects delivery of 3.8 million doses of AstraZeneca's vaccine in January and February next year and plans to begin inoculations in March.

China
China has not announced supply deals with Western drugmakers, which instead have partnered with private companies in the country.AstraZeneca's vaccine may be approved in China by mid-2021 and its Chinese partner Shenzhen Kangtai Biological Products Co Ltd plans annual production capacity of at least 100 million doses by the end of this year.
For the Pfizer/BioNTech vaccine, a unit of Shanghai Fosun Pharmaceutical Group Co Ltd plans a Phase II trial.
Tibet Rhodiola Pharmaceutical Holding Co is bringing in Russian vaccine candidate Sputnik V and plans early and mid-stage trials in China.
China has also approved three vaccine candidates developed by Sinovac Biotech Ltd and state-owned China National Pharmaceutical Group (Sinopharm) for emergency use, and Sinopharm hopes its two candidates will get conditional approval for general use this year.

Japan
Japan has deals to buy 120 million doses from Pfizer/BioNTech in the first half of next year and 120 million from AstraZeneca - the first 30 million of which will be shipped by March 2021 - and 250 million from Novavax.
It is also in talks with Johnson & Johnson and has a deal with Shionogi & Co Ltd.
Experts said vaccine makers would need to conduct at least Phase I and II trials in Japan before seeking approval for use.

South Korea
The country has deals to buy 20 million doses each from AstraZeneca, Pfizer and Moderna and another 4 million doses from Johnson & Johnson's Janssen, enough to cover up to 34 million people.It will procure additional doses for 10 million people through COVAX.Inoculation is likely to start in the second quarter of next year to allow time to observe possible side effects.

India
The head of the Serum Institute of India, which makes the AstraZeneca vaccine, said on Nov. 23 the positive late-state trial result of the candidate will allow it to seek emergency use approval by year-end, before securing approval for full introduction by February or March.
India also expects a government-backed vaccine to be launched as early as February. It is also conducting a late-stage trial of Sputnik V.

Taiwan
Taiwan aims to secure around 15 million doses initially, both via the COVAX scheme and by direct purchases from manufacturers, and may buy an additional 15 million doses.
The government has said it hopes to begin vaccinations in the first quarter next year.

Malaysia
The Southeast Asian nation has agreed to buy 12.8 million doses of the Pfizer vaccine, becoming the first country in the region to announce a deal with the U.S. drugmaker after some expressed reservations over the need for the ultra-cold storage that the vaccine requires.
Pfizer will deliver the first batch of 1 million doses in the first quarter of next year.

The Philippines
The archipelago announced a deal on Nov. 27 for 2.6 million doses of the AstraZeneca vaccine and is discussing a possible 1 million more, covering about 1% of a population of 108 million people.It is also seeking 20 million to 50 million doses from Sinovac and is in talks with others, including Pfizer.Vaccine makers can seek approval from Philippine regulators even if no clinical trial is conducted in the country.

Indonesia
Southeast Asia's most populous country has secured 125.5 million doses from Sinovac, 30 million from Novavax, is in talks with AstraZeneca and Pfizer to buy 50 million doses each, and expects to get 16 million from COVAX.Indonesia is testing Sinovac's vaccine and preparing mass vaccination for medical staff and other frontline workers to start as soon as late January.

Vietnam
A government official said COVAX vaccines would cover only 20% of the population and the country is likely to have a chance to secure separate deals soon, as demand is very high.

Bangladesh
Bangladesh signed a deal with India's Serum Institute to buy 30 million doses of the AstraZeneca vaccine.It also expects to receive 68 million doses from global vaccine alliance GAVI at a subsidised rate, a senior health ministry official said.

Posted by Pgraduate123 > 2020-12-11 16:37 | Report Abuse

NPRA - they left 2 months ago

Posted by whenarmada > 2020-12-11 16:38 | Report Abuse

this counter will take years to recover the above RM20. probably will never recover also

Posted by investmalysia > 2020-12-11 16:49 | Report Abuse

With the stingy dividend, better put your funds in topglove if you want to invest in glove companies

Posted by Gaussian > 2020-12-11 17:54 | Report Abuse

Today MacQ sell cheap tickets due to expiring warrants. Buy till syok syok. Will continue buying next week

Posted by ruhaizat69 > 2020-12-11 19:12 | Report Abuse

Tp8.45 for 2021

Posted by Pgraduate123 > 2020-12-11 20:10 | Report Abuse

8.45 for Dec 2020

Posted by Gaussian > 2020-12-11 20:27 | Report Abuse

Yes I will wait there

Posted by NPRA1985 > 2020-12-11 23:14 | Report Abuse

https://www.facebook.com/TheStarOnline/videos/1079247715850828/

Posted by huat8787 > 2020-12-11 23:15 | Report Abuse

https://www.sinchew.com.my/pad/con/content_2391872.html

Posted by huat8787 > 2020-12-11 23:16 | Report Abuse

Harta good news
https://www.sinchew.com.my/pad/con/content_2391872.html

Posted by Foker > 2020-12-12 02:47 | Report Abuse

Report Jeffrey Ng and YY Cheah to SC, both analyst at JP Morgan. Request for an investigation into these two individuals for market manipulating activities. What is the reason they start coverage on glove sector and immediately give an extremely low tp at 30% of consensus? If any hankypanky, their license should be revoked asap.

Posted by Legend > 2020-12-12 07:41 | Report Abuse

KUALA LUMPUR (Dec 11): JP Morgan has reinstated coverage of Top Glove Corp Bhd, but with an underweight recommendation and a fair value of RM3.50 — that's about half its current market price of RM6.90 — as it sees the passing of a supernormal growth cycle for glove makers, in anticipation of a huge oversupply in the market, as glove demand decelerates in tandem with the pace of testing for Covid-19.

Besides the world's largest rubber glove maker, it also initiated coverage of its closest peers Hartalega Holdings Bhd and Kossan Rubber Industries Bhd, also with UW ratings.

It gave a fair value of RM8.50 for Hartalega, down 38% from its last traded price of RM13.72, and a fair value of RM3.80 to Kossan, which is 30% less than its closing price of RM5.39 today.

Posted by GeniusTinker > 2020-12-12 08:49 | Report Abuse

Kenanga TP26.22
CIMB 24.8
PBB 24.5
HLB 24.1
Instead of reporting JP Morgan, why don’t you sue all these local IB analyst? Do you think their TP is achieveable and realistic?

Posted by gloveharicut > 2020-12-12 09:44 | Report Abuse

https://klse.i3investor.com/blogs/gloveharicut/2020-12-12-story-h1537539295-JP_Morgan_cut_GLOVES_target_price_Supernormal_Cycle_over_What_s_your_co.jsp

Posted by Mr.Sm Invest123 > 2020-12-12 09:46 | Report Abuse

JP Morgan pegs these glove makers' fair value at up to half their market price, says supernormal cycle is over

KUALA LUMPUR (Dec 11): JP Morgan has reinstated coverage of Top Glove Corp Bhd, but with an underweight recommendation and a fair value of RM3.50 — that's about half its current market price of RM6.90 — as it sees the passing of a supernormal growth cycle for glove makers, in anticipation of a huge oversupply in the market, as glove demand decelerates in tandem with the pace of testing for Covid-19.

Besides the world's largest rubber glove maker, it also initiated coverage of its closest peers Hartalega Holdings Bhd and Kossan Rubber Industries Bhd, also with UW ratings.

It gave a fair value of RM8.50 for Hartalega, down 38% from its last traded price of RM13.72, and a fair value of RM3.80 to Kossan, which is 30% less than its closing price of RM5.39 today.

Its analysts Jeffrey Ng and YY Cheah, in a note to clients today, said they expect glove prices to weaken in the second half of next year.

| https://www.klsescreener.com/v2/news/view/765419

Posted by stockraider > 2020-12-12 10:15 | Report Abuse

Get ready for the coming big upside potential of insas in view of its growth potential, value rerating and big improvement in financial stock business mah....!!

Jump in & buy big b4 too late loh....!!

INSAS IS A MISUNDERSTOOD STOCK LOH....!!

IF U LOOK BACK AT INSAS FOR PAST 10 YEARS, IT HAS BEEN CREATING VALUE NON STOCK ALMOST EVERY YEAR WITH INCREASING SHAREHOLDER FUND MAH...!!

THATS THE REASONS WHY ITS NTA GROW FROM RM 1.00 SAY 10 YEARS AGO TO ALMOST RM 4.00- 5.00 AS AT NOW MAH...!!

INSAS BIGGEST WINNER LIKE INARI, CONTRIBUTE MORE THAN RM 1.4B MARKET CAP & SMALLER WINNER LIKE SENGENIC CAN CONTRIBUTE MORE THAN RM 60M LOH...!!

SMALL INVESTMENT LIKE OMESTI & DGSB ARE DOING EXTREMELY WELL LOH...!!

INSAS IS LIKE BERKSHIRE HATHAWAY BUSINESS MODEL LOH...!!

BUT UNLIKE BERSHIRE, ACTUALLY INSAS IS BETTER IT PAYS DIVIDEND BUT BERSHIRE DON'T PAY LOH...!!

THOSE INVESTING IN INSAS IS GETTING COMPOUND GROWTH RETURN AVERAGING 10 TO 12% PA EVERY YEAR LOH....!!

IF U BUY INSAS NOW U R PAYING RM 0.865 FOR A FAIR VALUE OF RM 4.00 IN INSAS LOH....!!

A GREAT INVESTMENT LOH...!!

BUT MOST EXCITING PART THIS INSAS IS GROWING WITH GOOD PROFITABILITY MAH!


Just look at the amazing growth track record of value creation of insas for the past 10 yrs

Sept 2020- Nta Rm 2.75

June 2019- Nta Rm 2.62

Dec 2018- Nta Rm 2.54

Dec 2017..Nta rm 2.49

Dec 2016 ...Nta Rm 2.18

Dec 2015..Nta Rm 1.96

Dec 2014..Nta rm 1.82

Dec 2013 nta..rm 1.71

Dec 2012 nta ..rm 1.51

Dec 2011 nta..rm 1.38

Dec 2010 nta...rm 1.22

Dec 2009 nta ..rm 1.14

INSAS IS GROWING STRONGLY MAH....ONLY THOSE PEOPLE DO NOT UNDERSTAND BERKSHIRE HATHWAY BUSINESS MODEL ARE SAYING INSAS HATHWAY BUSINESS MODEL ARE LOUSY LOH...!!

BUT INSAS BUSINESS MODEL ARE SAME SAME MAH, IN FACT INSAS GENERATE COMPOUND EARNINGS OF 12% PA SAME SAME AS BERKSHIRE WOH..!!...HOW COULD BE BERKSHIRE VERY GOOD & INSAS VERY BAD LEH ??

Posted by Pgraduate123 > 2020-12-12 10:22 | Report Abuse

Stockraider, are you still in 1980's?

Posted by stockraider > 2020-12-12 10:24 | Report Abuse

U R DEAD DUCK STAYING WITH GLOVES LOH....!!

THE SHARE PRICE IS GOING TO BE CUT BY HALF DUE TO FUTURE OUR CAPACITY & GLOVES GLUT COMING LOH...!!

READ JP MORGAN REPORT, U BETTER RUN B4 TOO LATE MAH,,,!!


Posted by Pgraduate123 > Dec 12, 2020 10:22 AM | Report Abuse

Stockraider, are you still in 1980's?

Posted by stockraider > 2020-12-12 10:30 | Report Abuse

Glove production capacity, they noted, is expected to grow 87% in the next three- to five years from this year’s, with 130 billion pieces per annum capacity to come from the big four glove makers of Top Glove, Hartalega, Kossan and Supermax Corp Bhd, and 20 billion pieces more from non-conventional players.

“The most worrying factor is oversupply, as we see not only significant capex plans from the big four producers but also from new players. While it is hard to measure the potential oversupply, we can take a leaf from the crude palm oil industry which saw a decade of oversupply post a supernormal cycle in the early 2000s,” they noted.

Additionally, glove makers' profitability is expected to be negatively affected by higher raw material prices and rising labour costs. "Pressure on foreign workers' treatment has and will continue to lift opex. Board members of certain glove producers have also asked for a raise in board fees. All these will add to higher opex and erode margins," they wrote.

Amid all this, they think the upside potential for glove stocks may be capped, with retail and foreign participation having reached all-time highs.

Malaysia’s government linked funds are the only hope to lift the sector, they wrote, yet they have also been trimming their exposure recently.

"The market cap of the top-four producers is RM170 billion, equal to 66% of local non-government-linked funds’ AUM (asset under management). Our proprietary analysis shows most funds have exposure in gloves and their cash holdings are low. To date, local mutual funds have invested 11% of AUM in gloves. Retail and foreign participation are at all-time highs. It is thus difficult to find incremental dollars to drive this sector higher," the note read.

Meanwhile, they noted that Top Glove and Hartalega's capital management decisions have not been optimal for creating value for shareholders due to the focus on accelerating capex via cash to support capacity growth.